Australia's largest stock trading and investment forum Australia's #1 stock forum

CF1

10.0%

2.2¢ complii fintech solutions ltd

Personally i'm not concerned about them meeting any of the...

First 615 Last

Share
Profile

Follow
SamBrown1983

57 Posts.

1

03/10/17

11:40

Post #: 27617967
Share

Originally posted by finnind ↑

In my view - there is little to no chance of M4 being met.

That milestone was in play back when we had MOUs in play, potential big client such as NAB and a key client in Sentry who was potentially going to sign a binding agreement and roll out IAM Company wide.

Now we seem to have no MOUs in play, no potential big clients, limited commitment from Sentry and a Portal (hard to say how successful this is as the Company has not provided any details on up-take).

I too am a holder, but am struggling to see how this Company is going to meet the targets they set even though PC saying all is on track.

It seems to me that the risks and integration effort for Companies to adopt the product outweigh the benefits for now.

Expand

Personally i'm not concerned about them meeting any of the milestones - would prefer they fall just short on all of them.

Don't know why everyone seems to be so fixated on them./

IAM Price at posting: 1.2¢ Sentiment: Hold Disclosure: Held
6 Upvote

0 Great analysis

Reply

Top Stories

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

BUX

Buxton projects new graphite province discovery at WA Narryer play

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

There are more pages in this discussion • 108 more messages in this thread...

First 615 Last

Add CF1 (ASX) to my watchlist

(20min delay)
Last 2.2¢		Change 0.002(10.0%)		Mkt cap ! $12.58M

Open	High	Low	Value	Volume
2.1¢	2.2¢	2.1¢	$7.78K	360.6K

Buyers (Bids)

No.	Vol.	Price($)
1	103090	2.2¢

Sellers (Offers)

Price($)	Vol.	No.
2.3¢	300000	1

View Market Depth

No.	Vol.	Price($)
1	491617	0.020
1	200000	0.019
3	1434231	0.018
1	1000000	0.017
1	1000000	0.016

Price($)	Vol.	No.
0.023	300000	1
0.024	125000	1
0.026	64744	1
0.028	483161	1
0.030	827135	4

Last trade - 15.54pm 04/10/2024 (20 minute delay)

CF1 (ASX) Chart

Personally i'm not concerned about them meeting any of the...

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

BCI reaches close of funding facility for salt-first part of Mardie project

Buxton projects new graphite province discovery at WA Narryer play

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Personally i'm not concerned about them meeting any of the...

Top Stories

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

BCI reaches close of funding facility for salt-first part of Mardie project

Buxton projects new graphite province discovery at WA Narryer play

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News